Substance Use Disorders

Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion

Minds and Mentors Program- R33

Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)

Neuroimaging of Adolescent Cannabis Use Treatment

Characterization of Phenotypic and Genotypic Regressors for Imaging

Shared Decision Making to Treat Or Prevent (STOP) HIV in Justice Populations (R33)

Supporting Treatment Access and Recovery in Re-entry (STAR-R)

Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic

Recovery Inspired Support Engagement (RISE) Pilot

Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation

The Canadian Underage Substance Use Prevention Trial

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

Evaluation of RRFT for Co-occurring SUD and PTSD Among Teens

Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services

Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up

Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) in SUD Recovery

Family Support Protocol for Adolescent Internalizing Disorders

Peer-Delivered Behavioral Activation in a CCBHC

The Collaborative Care PrTNER Study